6:01 AM ET
8-K
Executive Compensation
Retension Pharmaceuticals Executive Compensation
Retension Pharmaceuticals appointed Robert Wong as Vice President and Chief Accounting Officer, effective November 2, 2026. His compensation package includes an annual base salary of $360,000, a 30% target bonus opportunity, a $20,000 sign-on bonus, and a stock option award for 25,000 shares.
- Counterparty
- Robert Wong